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Diabetes mellitus has assumed epidemic proportions in most parts of the world including the developing 
countries, and one of its ominous complications, diabetes nephropathy represent today the leading cause of end-
stage renal disease in the developed countries. However, the pathogenesis of diabetes nephropathy remains 
illusive, notwithstanding, free radicals seem to be the most favorable linkage between all the associated factors 
suggested. Consequently, free radicals, oxidative stress and antioxidants have become commonly used terms in 
modern discussions of renal disease mechanisms, making the kidney unique among other organs as the site in 
which a spectrum of seemingly unrelated diseases involves reactive oxygen species. Importantly, 
hyperglycaemia and its attendant metabolic syndromes, smoking and the use of xenobiotics have been shown to 
accelerate free radical generations and attenuate the antioxidant system creating oxidative stress. The 
management of diabetes nephropathy is extremely expensive and frustrating. Therefore, prevention is better. 
Sources of antioxidants, especially antioxidant vitamins are available and affordable in most environments. 
These may   be adjunct to other ways of preventing the development of diabetic nephropathy.  Reviews like this 
are necessary to stimulate stakeholders in management of diabetes mellitus and modern nephrologists.  
 





McCord and Fridovich opened the field of free 
radicals and oxidative stress when they discovered an 
enzyme superoxide dismutase (SOD). 1 Since then 
reactive oxygen species (ROS) has come to occupy an 
amazingly central role in a wide variety of diseases.  
Consequently, free radical, oxidative stress, and 
antioxidants have become commonly used terms in 
modern discussions of renal disease mechanisms, 
making the kidney unique among other organs as the 
site in which a spectrum of seemingly unrelated 
diseases involves ROS.  2 - 5
Diabetes mellitus and one of its complications, 
diabetic nephropathy, represent a leading cause of 
end-stage renal diseases (ESRD) in the developed 
countries especially United States and Europe.  6, 7  
Hyperglycaemia of diabetes mellitus and its 
attendant metabolic syndromes 8 - insulin resistance, 
hyperglycaemia, hypertension, dyslipidaemia, obesity, 
and some social characters of these patients e.g. 
smoking and the use of xenobiotics, predispose to 
diabetic nephropathy. These accelerate free radical 
generation and attenuate the antioxidant defense 
system creating oxidative stress 2, 9 - 13.Consequently, 
increased free radical production and attenuation of 
antioxidant system is currently receiving the highest 
attention when discussing diabetic nephropathy. 
Therefore, stakeholders in management of diabetes 
mellitus as well as modern nephrologists are 
recommended to eliminate or prevent the 
development of the sources of free radicals right from 




Pathogenesis of diabetic nephropathy 
 
The pathophysiology of diabetic nephropathy can be 
viewed as a sequence of events evolving in a stepwise 
pattern as shown in figure 1 and 2, where it starts with 
endothelial cell dysfunction (ECD) and ends with 
end-stage renal failure. However, ECD is preceded by 
glomerular hyperperfusion and hyperfiltration. 
 
The normal endothelial cell 
The last 20 years have brought about a lucid 
realization that far from being only an anatomic 
barrier to prevent the extravasations of circulating 
blood into the vessel wall, the endothelium is a
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metabolically active system that maintains vascular 
homeostasis, 6, 9, 14 - 18 by regulating the homeostatic, 
inflammatory, and reparative responses to local 
injuries mediated by NO by inhibiting the activation 
of an important nuclear transcription factor-Nuclear 
Factor kappa B (NFkB) that binds to the promoter 
regions of genes which code for proinflammatory 
proteins.  
Hence, NO production or availability can regulate 
diverse functions in endothelial cells. Therefore, any 
event that alters the function of NO will lead to 
endothelial cell dysfunction (ECD). 
 
Endothelial cell dysfunction (ECD) 
As any other organ, the vascular endothelium is 
subject to dysregulation, dysfunction, insufficiency, 
and failure. Endothelial cell dysfunction is therefore 
defined as decreased synthesis, release, and/or activity 
of endothelial-derived nitric oxide. 10 The 
pathophysiology of ECD expressed in various degrees 
is emerging as a hallmark of several highly prevalent 
renal as well as cardiovascular diseases and other 
chronic diabetic complications. 6
 
What triggers ECD in diabetes mellitus? 
A causal relationship between oxidative stress, ECD 
and diabetic nephropathy has been established 19 by 
observations that: 
a) High glucose can directly cause ECD and 
increases oxidative stress in glomerular 
mesangial cells, a target cell of diabetic 
nephropathy. 
b) Lipid peroxides and 8-hydroxydeoyguanosine, 
indices of oxidative tissue injury, were 
increased in the kidneys of diabetic rats with 
albuminuria. 
c) Oxidative stress induces mRNA expression of 
NFkB genes which in turn promotes production 
of proinflammatory proteins-TGF-B, 
fibronection, laminin, elastin, IL-1, IL-6, and 
PDGF, and 
d) Inhibition of oxidative stress ameliorates all the 
manifestation associated with ECD and diabetic 
nephropathy. 
Diabetic nephropathy is preceded by glomerular 
hypererfusion and hyper filtration, 7, 20 –22 which occur 
early in type 1 and in some 15-44% of type 2 diabetic 
patients at diagnosis, and these play a pathogenetic 
role in ECD, the early stage of diabetic nephropathy. 7, 
20, 21 The hyperinsulinaemia of diabetes mellitus cause 
increase reabsorption of glucose and sodium in the 
proximal convoluted tubule and synthesis of NO via 
activation of IRS-1, 2. The insulin resistance also 
diverts more glucose into the pentose phosphate 
pathway, resulting in increase activation of PKC 
pathway and increase glomerular prostaglandins 
production, afferent arteriolar dilatation and efferent 
arteriolar constriction. 7, 20 - 23 Hyperglycaemia 
depresses the synthesis of heparin sulphate 
proteoglycans with consequent impairment of 
electrostatic barrier. 20These factors associated with 
genetic factors, e.g., genetic polymorphism of ACE 
and the sodium/lithium counter transport gene, lead to 
glomerular hyperperfusion and hyperfiltration. 23 The 
high GFR (about 20-30% increase) in humans has 
been shown to be strongly associated with 
nephromegaly. 21 These factors do not induce such 
early glomerular events alone but in tandem with 
oxidative changes. 7, 20 - 23
There is little doubt that the primary causal factor 
for the development of most diabetic complications is 
prolonged exposure to hyperglycaemia. The 
mechanisms of damage involve, 20, 23, 25 onenzymatic 
glycation of proteins, flux of glucose through the 
sorbitol pathway, increased de novo synthesis of 
diacylglycerol and subsequent activation of the 
protein kinase C pathway, impairment of electrostatic 
barriers, and increased lipid peroxidation. These not 
only generate ROS but also attenuate antioxidant 
mechanisms creating a state of oxidative stress. 
The process of nonenzymatic reaction of glucose 
with proteins is well known phenomenon and has 
been proven to account for numerous features of 
chronic diabetic complications.  
Advance glycosylation end products (AGEs)- 
receptor specific interactions with endothelial cells 
and macrophages, binding to antioxidant enzymes, 
and lipoproteins can lead to widespread ECD. 6, 20, 26, 
27 Lipoprotein trapping and oxidation, deposition of 
AGEs in glomerular wall, inflammatory cell 
recruitment and activation, enhanced by clotting 
abnormalities and platelet activation, follow this. All 
these events augment production of free radicals. 6, 26, 
27 
There exist in diabetes alteration of blood pressure 
regulating system especially vascular reactivity as 
well as volume/sodium homeostasis. 28, 29 Adherence 
of diabetic red blood cells to endothelium results in an 
increase in production of lipid peroxides, and the 
resulting oxidant stress leads to a marked increase in 
PECAM-1 phosphorylations and transmigration of 
monocytic cells. Hyperglycaemia also promotes 
leukocytes adhesion to the endothelium through up 
regulation of cell-surface expression of adhesive 
proteins, and these processes depend on NF-Kb 
activation. These factors are part of the abnormal 
blood pressure deregulations.  
The glomerular endothelium experiences three 
primary mechanical forces, 32 the transmural pressure, 
the circumferential stretch (tension) and the shear 
stress. The altered blood pressure 
regulation/hypertension alters the shear stress.  This 
appears to result in altered Intercellular Adhesion 
Molecule (ICAM-1), Vascular Cell Adhesion 
Molecule (VCAM-1) expression and increase 
monocyte adhesions, suggesting that the endothelial 
cells exposed to chronic arterial hypertension may 
lead to progressive ECD and disrupt the filtration 
barrier. 28 This indicates that oxidative stress is 
eminent in diabetic hypertensive patients causing 
ECD and therefore diabetic nephropathy. 
Abnormalities in lipid metabolism and the 
potential nephrotocixity have been suggested more 
than a century ago, 30, 31 and these are evidence by. 32
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Figure 1: Sequence of events in the pathogenesis of diabetic nephropathy 
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High cholesterol diets are associated with 
albuminuria and glomerular injury, lipid lowering 
agents and intake of large amount of dietary omega-
n3 and –n6 reduced glomerular injury. Diabetes 
mellitus and renal tissue in this milieu has been 
suggested to accelerate oxidation of lipids. 6, 20, 23, 26. 
Diabetes mellitus as an oxidant milieu enhances free 
radical generation via; 6, 19, 33, 34 (a) non-enzymatic 
glycosylation of proteins (apolipoproteins, enzymes 
and receptors) leads to chronically elevated lipids and 
lipoproteins, (b) tincrease glucose metabolism through 
the aldose reductase pathways altering the 
intracellular redox balance, increase de novo synthesis 
of diacylglycerol and subsequent activation of PKC 
pathway, and the attenuation of antioxidant 
mechanisms create an oxidative stress. 
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These predispose the chronically elevated lipids 
and lipoproteins to free radical oxidation. It has also 
been found in diabetic patients that lipid peroxides 
and 8-hydroxydeoxyguanosine, indexes of oxidative 
tissue injury were increased in diabetic patients. The 
oxidized lipids are toxic to tissues especially the 
vascular endothelium, glomerular mesangial cells, 
smooth muscle cells and renal tubular epithelium. 
Under this milieu the major cells of the glomerular 
wall can carry out lipid oxidation. 2 - 4, 20, 25, 26 Oxidized 
LDL exerts many biological effects that may 
contribute to the ECD and progression of diabetic 
nephropathy (table 1). 11, 32, 34, 35
Although the above considerable evidence support 
the notion that lipid abnormalities contribute to renal 
injury in animal models of endogenous and diet-
induced hyperlipidaemia, not all models of 
hyperlpidaemia develop renal injury. 30This apparent 
paradoxical relationship between 
hypercholesterolaemia, atherosclerosis and glomerular 
injury in these models could be the result of 
differences in types of plasma lipoprotein. 30
Obesity, diabetes mellitus, dyslipidaemia and 
hypertension are common, interrelated medical 
problems, and are associated with an increased risk of 
ECD, vascular as well as glomerular diseases.
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Cigarette smoking is shown to impose oxidative 
stress to the body generally, and this may enhance 
progression of ECD and therefore diabetic 
nephropathy. 13
The use of xenobiotic drugs by diabetic patients 
may also contribute to the development oxidative 
stress in the body and the kidney in particular. 13
 
 
Table 1: Oxidized lipids in ECD 
 
1. Oxidized LDL reduces vascular production of prostacyclins and EDGF (NO) and enhances production 
of thromboxane A2 and Endothelin-1. 
2. Oxidized is immunogenic. Immune complexes of LDL aggregates are efficiently internalized by 
macrophages via Fc-receptor. Antibodies to epitopes on oxidized LDL have been demonstrated in 
patients with diabetes mellitus. 
3. Oxidized lipid alters expression of receptors and change membrane signal transudations. 
4. Oxidized lipid can adversely initiate coagulation system by tissue factor and plasminogen activator 
inhibitor-1 synthesis. 
5. Through the above mechanisms oxidized LDL induces leukocyte-endothelial cell adhesion and 
promotes secretion of monocyte chemotactic protein-1 (MCP-1) and macrophage colony-stimulating 
factor (MCS) by endothelium.  
6. Oxidized lipid is a chemo attractant for monocytes and T-lymphocytes and via MCS; it inhibits 
macrophage motility in vascular wall. 
7. Oxidized LDL induces macrophages to produce toxic ROS, cytokines, proteases, and growth factors. 
8. Oxidized lipids enhance endothelial cell production of superoxide anions. 
9. Oxidized lipids suppress glomerular epithelial cell sterol synthesis and increase cholesterol ester 
formation. 
10. Oxidized LDL stimulates expression of several genes in the glomerular wall e.g. NF-Kb and IL-1, and 
their dependent cytokines and adhesion molecules e.g. VCAM-1, ICAM-1, P-selectin, and Endothelin-1. 
11. Oxidized lipoproteins and lipid hydroperoxides induce apoptosis. 
 
 
Tubulointerstitial nephritis  
In the past, most nephrologists considered the amount 
of protein found in the urine, simply as a marker of 
the severity of renal lesion. Today the results of many 
studies, 36,37 indicate that protein filtered through the 
glomerular capillaries have intrinsic renal toxicity, 
which together with other independent risk factors, 
can play a contributory role in the pathogenesis of 
renal damage. 7, 38 Plasma proteins reaching the 
tubular fluid are endocytosed by receptor mediated or 
constitutional pathway, 39 and degraded by lysosomes 
into their constituent amino acids. However, the 
reserve capacity for this process is limited and 
increasing the protein load leads to organelle 
congestion, lysosomal swelling and rupture eventually 
exposing renal interstitium to the injurious effect of 
lysosomal enzymes. 39,40 These up-regulate many NF-
kB dependent or independent genes potentially 
capable of triggering interstitial reactions, 36 and 
generation of ROS, but in some other instances such a 
relationship of protein overloading and interstitial 
inflammation appears less evident. However, a critical 
review of these studies show that these opinions were 
essentially based on proteinuria in range of 50-
70mg/24hr, 41 and short-term study periods, 41,42 
making it difficult to derive any definitive conclusion. 
The deleterious effects of glomerular macromolecular 
traffic and proximal tubular reabsorption on the 
kidneys are not only limited to the protein component 
alone. Plasma fatty acids bound to albumin by high 
affinity are filtered together into the renal tubules and 
are also endocytosed by PCT. The metabolites of 
these fatty acids are chemotatic and toxic to the renal 
tissues hence promoting interstitial nephritis. 7   
In the setting of tubulointerstitial disease, 
oxidative stress may directly originate from interstitial 
inflammatory cells, from pathologic events arising 
from or related to glomerular damage, or from 
metabolic adaptations occurring in the surviving 
nephrons. 5,43,44 Glomerular disease in diabetes allows 
leakage of red blood cells, a good source of iron, into 
the urinary space. Consequently human conditions 
associated with clinical proteinuria particularly 
diabetic nephropathy, iron excretion in urine is 
elevated. 34 Iron catalyzes oxidative reaction on the 
epithelial surface or intracellularly via Fenton 
reaction, producing highly damaging hydroxyl 
radicals. 13  
The metabolic burden imposed on remnant 
nephrons obligates increased oxygen consumption in 
surviving nephrons, and incurs increased generation 
of ROS. 45,46
Neutrophils and activated macrophages are rich 
source of ROS. These ROS produced under different 
mechanisms activate NFkB genes with increased 
production of NFkB gene-dependent cytokines, which 
independently or synergistically lead to messangial 
cell proliferations, extracellular matrix expansion, and 
renal mass fibrosis. 
The ESRD also is good source of free radical 
generation. It has been found that atherosclerosis is 
common in patients with end-stage renal disease. This 
is not merely reflects the high prevalence of the 
traditional cardiovascular risk factors such diabetes
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and hypertension but an independent effect of ESRD 
on the vasculature. 47 The association of ROS and 
atherosclerosis is a well-known phenomenon. ESRD 
accelerates generation of free radical via the metabolic 
burden imposed on remnant nephrons obligating 
increase oxygen consumption, the dyslipidaemia, 
hyperhomocycteinaemia, and hypertension, which are 
commonly associated with the ESRD. This explains 
the vicious cycle demonstrated in figure 1.   
There is therefore a gradual and chronic 
effacement of nephrons with consequent deterioration 
of renal functions culminating into renal failure.  
Therefore, the role of free radicals in the 
pathogenesis of ECD and hence diabetic nephropathy 
are as summarized in table 2. 
 
 
Table 2: Free radicals in ECD and diabetic nephropathy 5,9-11,36
 
1. Superoxide anions and other free radicals oxidize nitric oxide to metabolites e.g. peroxynitrite, which 
are potentially harmful to the endothelium. 
2. ROS may trigger contraction of the mesangium, afferent and efferent arterioles via PAF, cGMP, 
thromboxanes, and hence modulation of glomerular profile. 
3. ROS trigger CDb11/CD18-dependent cell adhesion and can stimulate the synthesis of PAF. PAF is 
autacoids with potent vasoactive and inflammatory properties and can stimulate mesangial cells to 
produce more hydrogen peroxide. 
4. Hydrogen peroxide is a potent activator of neutrophils and their subsequent adhesion to the endothelial 
cell surfaces. 
5. ROS e.g. superoxide anions, hydroxyl radicals, hydrogen peroxide, peroxynitrite, generated by 
inflammatory cells in the glomeruli, contribute to lipids peroxidation, forming an accelerated vicious 
cycle. Hypochlorous acids produced from hydrogen peroxide and halides, e.g. chlorine by 
myeloperoxidase. 
6. Hypochlorus acid reacts with ammonia to form chloramines. Ammonia is abundant in renal cells and 
urinary space. Chloramines are long-lived oxidants. 
7. Oxidants generated via myeloperoxidase-hydrogen peroxide-halide system derived from neutrophils 
inactivates inhibitors of proteolytic enzymes such as elastase, thus accelerate ECD.  
8. Superoxide anions can stimulate the NF-kB gene and its dependent genes with subsequent production of 
cell adhesion molecules (VCAM-1and ICAM-1) and vasoconstrictors e.g. Endothelin-1 and E-selectin. 
These facilitate cell adhesion to the endothelium. 
9. ROS can cause apoptosis of the endothelial cells.  
 
 
Consequently, oxidative stress is surely an 
inevitable accompaniment of diabetic nephropathy 
(see fig. 1 and 2 and tables 1 and 2). Therefore, how 
can diabetic nephropathy-related oxidative stress be 
dealt with? Eating a diet rich in fruits and vegetables 
will ensue adequate levels of antioxidant nutrients in 
the tissue and help the body to resists disease-related 
oxidative stress. 13 Fruits and vegetables are available 





An understanding of the homeostatic function of the 
glomerular endothelium is important for the modern 
nephrologist. The role of nitric oxide in mediating 
many of the regulatory properties of the endothelium 
is now recognized, as well as a growing 
understanding of how excess free radicals, generated 
under hyperglycaemia and its associated metabolic 
syndromes considered to be risk factors for diabetic 
nephropathy, cause endothelial cell dysfunction with 
loss of nitric oxide bioavailability. 
Because many antioxidant therapies appear 
capable of improving endothelial cell function and the 
fact that administration of L-arginine has restored 
different experimental nephropathies, including 
experimental diabetic nephropathy, causal 
relationship between improved endothelial cell 
function and diabetic nephropathy can be investigated 
in humans. 
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